...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Presentation at 12:45 today... link>

It looks like they made a mistake and initially listed the presentation as 2016.  It has just been updated to 2017.  Great impression made to potential investors, mistake on the first page of the slide...

Share
New Message
Please login to post a reply